Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Zepbound
Zepbound
Weight Loss From GLP-1 Drugs Not As Robust In Real-World Settings
Forbes
Wed, 10/2/24 - 11:20 am
weight loss
obesity
GLP-1 agonist
Ozempic
Wegovy
Novo Nordisk
Zepbound
Mounjaro
Eli Lilly
Inside the GLP-1 'price war'
Beckers Hospital Review
Tue, 09/24/24 - 11:52 am
GLP-1 agonists
obesity
weight loss
Eli Lilly
Novo Nordisk
Ozempic
Wegovy
Zepbound
Mounjaro
drug pricing
New research could ease concerns over suicide risk of obesity drugs
BioPharma Dive
Tue, 09/3/24 - 05:58 pm
obesity
suicide
GLP-1
Novo Nordisk
Eli Lilly
Ozempic
Wegovy
Mounjaro
Zepbound
Eli Lilly’s lauded discount of its obesity drug Zepbound comes with caveats
Stat
Wed, 08/28/24 - 09:24 pm
Eli Lilly
Zepbound
DTC
Lilly launches smallest single-dose vials of Zepbound for $399
Reuters
Tue, 08/27/24 - 11:16 am
Eli Lilly
Zepbound
Lilly’s tirzepatide cuts diabetes risk, study data show
BioPharma Dive
Tue, 08/20/24 - 11:54 am
Eli Lilly
tirzepatide
Mounjaro
Zepbound
type 2 diabetes
diabetes
clinical trials
Forget Mounjaro: Eli Lilly's Next Big Blockbuster Has Arrived
Motley Fool
Sun, 08/18/24 - 09:19 pm
Eli Lilly
FDA
obesity
Zepbound
Lilly demands doctors stop selling copycat weight-loss drugs
Reuters
Thu, 08/15/24 - 11:50 am
Eli Lilly
drug counterfeiting
Zepbound
weight loss
Weight-loss drugs like Wegovy may help stave off some cancers
NPR
Mon, 08/12/24 - 11:28 am
cancer
GLP-1 agonist
Wegovy
Zepbound
Novo Nordisk
Eli Lilly
Lilly boosts outlook on rising Zepbound revenue
BioPharma Dive
Thu, 08/8/24 - 11:19 am
Eli Lilly
earnings
Zepbound
FDA says all doses of Lilly's weight-loss and diabetes drug are now available
Reuters
Sun, 08/4/24 - 06:44 pm
Eli Lilly
FDA
Zepbound
Mounjaro
drug shortages
Lilly CEO says weight-loss drug shortage to end 'very soon', Bloomberg News reports
Reuters
Thu, 08/1/24 - 11:13 pm
Eli Lilly
weight loss
Zepbound
drug shortages
Lilly says weight loss drug cuts heart failure risk by 38% in trial
Reuters
Thu, 08/1/24 - 11:08 am
Eli Lilly
Zepbound
heart failure
GLP-1 drugs are driving up healthcare costs
Medical Marketing and Media
Fri, 07/26/24 - 11:03 am
obesity
weight loss
GLP-1 agonist
healthcare costs
Eli Lily
Novo Nordisk
Wegovy
Zepbound
NC Medicaid to cover weight-loss drugs like Wegovy, after access cut for state workers
Yahoo/Raleigh News & Observer
Mon, 07/22/24 - 06:48 pm
Novo Nordisk
Eli Lilly
obesity
Wegovy
Zepbound
North Carolina
Medicaid
Will Eli Lilly overtake Novo Nordisk in weight-loss drug race?
BioSpace
Tue, 07/16/24 - 12:11 pm
Eli Lilly
Novo Nordisk
Wegovy
Zepbound
weight loss
Patients on weight-loss drugs should inform doctor before surgery, EU regulator says
Reuters
Fri, 07/12/24 - 11:16 am
EMA
Novo Nordisk
Ozempic
Wegovy
Eli Lilly
Mounjaro
Zepbound
surgery
House committee backs some Medicare cover for obesity drugs
Pharmaphorum
Fri, 06/28/24 - 11:13 am
legislation
Medicare
obesity
Wegovy
Zepbound
House panel proposes new strategy for Medicare to cover weight loss drugs Wegovy, Zepbound
Stat
Thu, 06/27/24 - 11:13 am
Novo Nordisk
Medicare
Wegovy
Zepbound
Eli Lilly
legislation
Lilly Sees Path for Zepbound’s Label Expansion With Phase III Sleep Apnea Win
BioSpace
Mon, 06/24/24 - 11:20 am
Eli Lilly
Zepbound
clinical trials
sleep apnea
Pages
1
2
3
next ›
last »